Jobs on TAL
All jobsOnsiteResearchhealthtechExperience not specifiedantibody engineering
OnsiteLeadhealthtech

Group Lead - Antibody Engineering

Singular: Building Brilliant BiotechsSingaporePosted 20 May 2026

Singular is hiring a Group Lead, Antibody Engineering to build an RNA-therapeutics platform in Singapore. The role involves leading AOC engineering, overseeing bioconjugation strategies, and managing discovery workflows. The successful candidate will lead a team of scientists and drive programmes from design to candidate selection. This is a discovery-heavy leadership position within a rapidly scaling organisation.

Matched by TAL

50k new jobs listed every day. Install TAL to find more jobs like this.

Install TAL

Experience

Experience not specified

Function

Research

Work mode

Onsite, Singapore

Company

Tier 2

What you will work on

Singular is hiring a Group Lead, Antibody Engineering to build an RNA-therapeutics platform in Singapore. The role involves leading AOC engineering, overseeing bioconjugation strategies, and managing discovery workflows. The successful candidate will lead a team of scientists and drive programmes from design to candidate selection. This is a discovery-heavy leadership position within a rapidly scaling organisation.

TAL's take

Quality 60/1005/5 clarityTier 2 company

Well-defined leadership role in a scaling biotech initiative with clear strategic impact.

JD provides clear responsibilities, team size context, and specific technical focus.

Must haves

  • Strong background in antibody engineering or related modalities
  • Deep experience developing assays and validating conjugates
  • Ability to run full discovery flow-schemes
  • Experience building and managing teams

Tools and skills

antibody engineeringbioconjugationassay developmentantibody-oligo conjugatesconjugation strategies

About the company

Unfamiliar company in the biotech space, default tier 2.

Posts mentioning Singular: Building Brilliant Biotechs

Singular vs Appsflyer vs Branch vs Adjust?

What's your take on these MMP vendors on the following parameters: A) Product B) Customer support C) Integrations D) Ease of use - data accuracy, robustness E) Market share F) Pricing - cost effectiveness, hidden charges G) Growth of company -- given all these vendors are HQed outside India and rigorously expanding in India market, which verticals (e.g. Gaming, Fintech etc) and use case (e.g. Attribution etc) they dominate/lack for a specific verticals/category I am aware Appsflyer by far has captured a large space here but I have been hearing mixed reviews for leaders like these. Would love POVs from hands-on marketers/product folks or sales folks at these orgs. Thanks!

Indian Startups102

How could banks have better managed their exposure to Archegos Capital Management?

Come again? Do I need to sound like an arrogant bastard again that does not comply with political correct woke tea drinking HR habits? The banks who lost money because of Archegos Capital Management were not banks. Because they had no one employed with any living active brain-cell. Empty dead zombie meat-bags with an battery around their finger to bash a keyboard. The people who worked in ‘firms’ who held that piece of crap; had never opened a finance book, a math book, let alone if they even finished with LEGO’s or Duplo’s. You see; people wonder how others could have been so stupid to not have seen it coming. If you are one of those; I don’t know what to tell you. I hope you have a friend who slaps you back into reality. Evidence? Take the shit-show at Carvana; Oh boy; 50bn marketcap. Oh but what do I see here? what an immensive impressive earnings number. So why on earth are they so high? Except for the folks who know me; they know why this turd is overvalued; for the others; 1. Carvana has harakiri go-kill-yourself-issued debt bonds at yields I would I get a heart attack from 2. high yields; means I aint earning shit out of my products; because every bloody penny I earn I either pay off my debt; or I have to use more debt to pay off other debt. 3. but why are they so high? 4. because high yield ETfs all bought this rubbish because this ponzi scheme twiddly dick brainless oaf of a firm simply over inflates as it sits in these ETFs who buy it; 5. but if you say they basically suck, shouldn’t they have a bad credit rating? They do; 6. CCC+ - > this is not investment grade, this isn’t even gambling, this is purely russian roulette. and that’s what happened at Archegos Capital. There wasn’t a singular employee who had any knowledge of anything finance related. I’m sure they couldn’t even find the toilet if they had to. And yes, CVNA is toast as well; unless you feel restructuring debt for the sake of restructuring debt is healthy.

Personal Finance311

Uniqus Eyes $20 Mn in Series C Funding

- Uniqus is in advanced discussions to raise up to $20 Mn in its Series C funding round, valuing the company at $200-250 Mn. - The startup is negotiating with prominent investors including WestBridge, Accel, Norwest, Lightspeed, Bessemer Venture Partners, and Peak XV, alongside existing backers. - Founded in 2022, Uniqus specializes in ESG and accounting consulting, operating in eight cities globally with over 500 employees. - Last year, Uniqus secured $10 Mn in its Series B round to enhance growth and scale existing solutions and technology. - The enterprise tech sector is poised for significant investment growth, with early-stage startups like Singulr AI and Gyaan AI raising substantial funds recently. Source: [Inc42](https://inc42.com/buzz/uniqus-in-talks-to-raise-20-mn-in-fresh-funding-round/)

News Discussion40